Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT: Everolimus and Low-dose Tacrolimus for Prevention of NODAT in Renal Transplant Recipients
NCT02036554Phase 4Unknown
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Mar 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in diabetes mellitus (DM), sponsored by Seoul St. Mary's Hospital. Status: unknown.
02
Drugs
everolimus
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02036554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02036554.